524606 — Beryl Drugs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹125.22m
- IN₹144.92m
- IN₹188.20m
Annual cashflow statement for Beryl Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.5 | 9.84 | 10.1 | 8.66 | 5.88 |
| Depreciation | |||||
| Non-Cash Items | 2.92 | 2.88 | 3.25 | 3.96 | 2.11 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.15 | 3.94 | -17.2 | 1.29 | 13.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.87 | 24.8 | 8.2 | 26.4 | 36.5 |
| Capital Expenditures | -4.16 | -15.6 | -13.5 | -21.9 | -38.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 9.53 | 2.62 | 2.7 | 17.9 | 16.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 5.38 | -13 | -10.8 | -3.97 | -21.6 |
| Financing Cash Flow Items | -4.34 | -4.16 | -4.49 | -5.3 | -3.44 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.32 | -11.7 | 1.03 | -15.5 | -20.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.81 | 0.117 | -1.58 | 6.89 | -5.41 |